During a review of the patient's neurostimulator data on (b)(6) 2016, neuropace personnel noted that there was a change in signals noted on the patient's right depth lead indicative of a fracture.The treating physician was notified of this prior to the patient's appointment.During the patient appointment, another impedance measurement was taken which demonstrated "insufficient charge" on 3 of the 4 electrodes.Therefore, the physician elected to disable detection and stimulation on that lead and monitor the patient's response.As of a year later, the patient reported no seizures and was doing well.As of (b)(6) 2017, the neuropace field clinical engineer was informed that the lead had been explanted on (b)(6) 2016.The explanted product was returned to neuropace for investigation.It was reported that the neurosurgeon used a dog bone to secure the depth lead and then used a weck hemolock to mark the location where the lead entered the brain.The investigation was inconclusive.Only a partial lead was returned; the distal end of the lead was missing.The lead appeared to be damaged significantly during the explant process which impeded identification of the cause of the lead break.The patient remains implanted with the rns system neurostimulator and two depth leads with both detection and stimulation currently enabled.
|